![]() |
![]() |
Legal status
Patent in force
(51) | INT.CL. | A61K 38/36 | (2006.01) |
A61K 38/37 | (2006.01) | ||
A61P 7/04 | (2006.01) |
(11) | Number of the document | 2717905 |
(13) | Kind of document | T |
(96) | European patent application number | 12728919.7 |
Date of filing the European patent application | 2012-06-11 | |
(97) | Date of publication of the European application | 2014-04-16 |
(45) | Date of publication and mention of the grant of the patent | 2018-05-23 |
(46) | Date of publication of the claims translation | 2018-10-10 |
(86) | Number | PCT/US2012/041957 |
Date | 2012-06-11 |
(87) | Number | WO 2012/171031 |
Date | 2012-12-13 |
(30) | Number | Date | Country code |
201161495884 P | 2011-06-10 | US | |
201161511901 P | 2011-07-26 | US | |
201161523790 P | 2011-08-15 | US |
(72) |
SCHEIFLINGER, Friedrich, AT
TURECEK, Peter, AT
EWENSTEIN, Bruce, US
WONG, Wing, Yen, US
SUITER, Tobias, M., AT
|
(73) |
Takeda Pharmaceutical Company Limited,
1-1, Doshomachi 4-chome, Chuo-ku, Osaka-shi, Osaka,
JP
|
(74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
(54) | Krešėjimo ligos gydymas skiriant rekombinantinį VWF |
TREATMENT OF COAGULATION DISEASE BY ADMINISTRATION OF RECOMBINANT VWF |
Payment date | Validity (years) | Amount | |
2025-05-20 | 14 | 289.00 EUR |
2026-06-11 |